Today is August 27, 2024.
All times in Eastern Daylight Time.
-
Kopin Corporation Schedules Second Quarter 2024 Earnings Call Thursday, August 8, 2024 at 8:30am ET
WESTBOROUGH, Mass.--(BUSINESS WIRE)--Kopin Corporation (NASDAQ: KOPN), a pioneering provider of application-specific optical solutions and high performance microdisplays for defense, enterprise, co... more »
-
Longboard Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Corporate Updates
LA JOLLA, Calif.--(BUSINESS WIRE)--Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological ... more »
-
Arcturus Therapeutics to Present at Canaccord Genuity 44th Annual Growth Conference
SAN DIEGO--(BUSINESS WIRE)--Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a global messenger RNA medicines company focused on the development of infectious disease ... more »
-
OneSpan Reports Second Quarter 2024 Financial Results
BOSTON--(BUSINESS WIRE)--OneSpan Inc. (NASDAQ: OSPN), the digital agreements security company, today reported financial results for the second quarter ended June 30, 2024. “I’m extremely proud of o... more »
-
Vir Biotechnology Acts on Expanded Strategy of Powering the Immune System Through Exclusive Worldwide License Agreement with Sanofi for Multiple Potential Best-in-Class Clinical-Stage T-cell Engagers
SAN FRANCISCO--(BUSINESS WIRE)--Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that it has entered into an exclusive worldwide license agreement with Sanofi for three clinical-stage masked T... more »
-
Axonics Reports Second Quarter 2024 Financial Results
IRVINE, Calif.--(BUSINESS WIRE)--Axonics, Inc. (Nasdaq: AXNX), a medical technology company that develops, manufactures and commercializes innovative and minimally invasive products to treat bladde... more »
-
Upland Software Reports Second Quarter 2024 Financial Results
AUSTIN, Texas--(BUSINESS WIRE)--Upland Software, Inc. (Nasdaq: UPLD), a leader in cloud-based tools for digital transformation, today announced financial and operating results for the second quarte... more »
-
DexCom, Inc. (DXCM) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
NEW YORK--(BUSINESS WIRE)--Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of DexCom, Inc. (“DexCom” or “the Company”) (NASDA... more »
-
NuScale Power Corporation (SMR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
NEW YORK--(BUSINESS WIRE)--Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of NuScale Power Corporation (“NuScale” or “the Co... more »
-
Corsair Gaming Reports Q2 2024 Financial Results
MILPITAS, Calif.--(BUSINESS WIRE)--Corsair Gaming, Inc. (Nasdaq: CRSR) (“Corsair” or the “Company”), a leading global provider and innovator of high-performance products for gamers, streamers, cont... more »
-
Greenidge Provides Bitcoin Production Update
DRESDEN, N.Y.--(BUSINESS WIRE)--Greenidge Generation Holdings Inc. (NASDAQ: GREE) (“Greenidge” or the "Company"), a vertically integrated cryptocurrency datacenter and power generation company, tod... more »
-
NANO Nuclear Energy Inc. (NNE) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
NEW YORK--(BUSINESS WIRE)--Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of NANO Nuclear Energy Inc. (“NNE” or “the Company”... more »
-
Beacon Reports Second Quarter 2024 Results
HERNDON, Va.--(BUSINESS WIRE)--Beacon (Nasdaq: BECN) (the “Company”, “we”, “our”), the leading publicly-traded wholesale distributor specializing in roofing, waterproofing, and exterior products, a... more »
-
Cerus Corporation Announces Second Quarter 2024 Financial Results and Increases Full-Year 2024 Product Revenue Guidance Range
CONCORD, Calif.--(BUSINESS WIRE)--Cerus Corporation (Nasdaq: CERS) today announced financial results for its second quarter and six months ended June 30, 2024. Total revenue for the three and six m... more »
-
Bally’s Corporation (BALY) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
NEW YORK--(BUSINESS WIRE)--Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Bally’s Corporation (“BALY” or “the Company”) (N... more »
-
Adicet Bio to Participate in Upcoming Investor Conferences
REDWOOD CITY, Calif. & BOSTON--(BUSINESS WIRE)--Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoim... more »
-
Maiden Holdings, Ltd. to Release Second Quarter 2024 Earnings on August 8, 2024
PEMBROKE, Bermuda--(BUSINESS WIRE)--Maiden Holdings, Ltd. ("Maiden") (NASDAQ: MHLD) announced it plans to release its second quarter 2024 financial results after the market closes on Thursday, Augu... more »
-
Distribution Dates and Amounts Announced for Eaton Vance Closed-End Funds
BOSTON--(BUSINESS WIRE)--The following Eaton Vance closed-end funds (the “Funds”) announced distributions today as detailed below. Declaration – 8/1/2024 Ex-Date – 8/12/2024 Record – 8/12/2024 Paya... more »
-
International Bancshares Corporation Announces Cash Dividend
LAREDO, Texas--(BUSINESS WIRE)--International Bancshares Corporation announced that IBC’s Board of Directors approved the declaration of a cash dividend for shareholders of record. more »
-
US FDA expands Jemperli (dostarlimab-gxly) plus chemotherapy approval to all adult patients with primary advanced or recurrent endometrial cancer as the first and only immuno-oncology-based treatment to show an overall survival benefit
PHILADELPHIA--(BUSINESS WIRE)--Expanded approval of Jemperli (dostarlimab-gxly) plus chemo in endometrial cancer as first & only IO-based treatment to show overall survival benefit more »
-
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Paragon 28, Inc. (FNA) on Behalf of Investors
LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Paragon 28... more »
-
Ameriprise Financial Welcomes $150 Million UBS Advisor Looking for Greater Support and an Empowering Culture
MINNEAPOLIS--(BUSINESS WIRE)--Financial advisor Michael Walstien joined Ameriprise Financial from UBS with $150 million in assets to receive greater support to serve clients. more »
-
PURE Bioscience Announces Distribution Agreement with ChemStation
EL CAJON, Calif.--(BUSINESS WIRE)--PURE Bioscience, Inc. (OTCQB: PURE) (“PURE,” the “Company” or “we”), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial, and ChemStat... more »
-
Microvast Schedules Second Quarter Earnings Call
STAFFORD, Texas--(BUSINESS WIRE)--Microvast Holdings, Inc. (NASDAQ: MVST), (“Microvast” or the “Company”), a technology innovator that designs, develops and manufactures lithium-ion battery solutio... more »
-
Xerox Holdings Corporation Declares Dividend on Common and Preferred Stock
NORWALK, Conn.--(BUSINESS WIRE)--Xerox Holdings Corporation (NASDAQ: XRX) announced today that its board of directors declared a quarterly dividend of $0.25 per share on Xerox Holdings Corporation ... more »
|
|